Skip to Content

Notice

Exempt Chemical Preparations Under the Controlled Substances Act

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Drug Enforcement Administration (DEA), Department of Justice.

ACTION:

Order with opportunity for comment.

SUMMARY:

The applications for exempt chemical preparations received by DEA between July 1, 2012, and March 31, 2013, as listed below, were accepted for filing and have been approved or denied as indicated.

DATES:

Electronic comments must be submitted and written comments must be postmarked on or before September 3, 2013. The electronic Federal Docket Management System will not accept comments after midnight Eastern Time on the last day of the comment period.

ADDRESSES:

To ensure proper handling of comments, please reference “Docket No. DEA-372” on all electronic and written correspondence. DEA encourages that all comments be submitted electronically through http://www.regulations.gov using the electronic comment form provided on that site. An electronic copy of this document is also available at http://www.regulations.gov for easy reference. Paper comments that duplicate the electronic submission are not necessary as all comments submitted to www.regulations.gov will be posted for public review and are part of the official docket record. Written comments submitted via regular or express mail should be sent to the Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODL, 8701 Morrissette Drive, Springfield, Virginia 22152.

Start Further Info Start Printed Page 40176

FOR FURTHER INFORMATION CONTACT:

John W. Partridge, Executive Assistant, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 307-7165.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Posting of Public Comments

Please note that all comments received are considered part of the public record and made available for public inspection online at http://www.regulations.gov and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter.

If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted.

If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be posted online or made available in the public docket.

Personal identifying information and confidential business information identified and located as set forth above will be redacted, and the comment, in redacted form, will be posted online and placed in DEA's public docket file. Please note that the Freedom of Information Act applies to all comments received. If you wish to inspect the agency's public docket file in person by appointment, please see the FOR FURTHER INFORMATION CONTACT paragraph.

Legal Authority

DEA implements and enforces Titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970, often referred to as the Controlled Substances Act and the Controlled Substances Import and Export Act (codified at Title 21, Chapter 13 of the U.S.C.), as amended (CSA). DEA drafts and publishes the implementing regulations for these statutes in Title 21 of the Code of Federal Regulations (CFR), parts 1300 to 1321. The CSA and its implementing regulations are designed to prevent, detect, and eliminate the diversion of controlled substances and listed chemicals into the illicit market while providing for a sufficient supply of controlled substances and listed chemicals for legitimate medical, scientific, research, and industrial purposes. Controlled substances have the potential for abuse and dependence and are controlled to protect the public health and safety.

Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).[1] DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Deputy Assistant Administrator may exempt a chemical preparation or mixture from the application of certain provisions of the CSA. The Deputy Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.

Exempt Chemical Preparation Applications Submitted Between July 1, 2012, and March 31, 2013

The Deputy Assistant Administrator received applications between July 1, 2012, and March 31, 2013, requesting exempt chemical preparation status pursuant to 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or other animal and either: (1) Contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse; if the preparation or mixture contains a narcotic controlled substance, it must be formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects if abused, and so that the narcotic substance cannot in practice be removed.

Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Deputy Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA, are exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date listed below that was provided in the approval letters to the individual requesters.

Chart I

SupplierProduct nameFormApplication date
AccuStandard, IncAPP-9-086, a,a-DimethylphenethylamineAmber ampule: 1 mL1/28/2013
AccuStandard, IncAPP-9-086-20X, a,a-DimethylphenethylamineAmber ampule: 1 mL1/28/2013
AccuStandard, IncAS-E1179, Chloral hydrateAmber ampule: 1 mL1/28/2013
AccuStandard, IncCLP-HC-X1, Composite Mix #3AAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-551.1B, Disinfectant by-productsAmber ampule: 1 mL1/28/2013
Start Printed Page 40177
AccuStandard, IncM-551B, Disinfectant by-productsAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-551B-2, Chloral hydrateAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-8015B/5031-21, ParaldehydeAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-8206B-05, Additional VOC's by Method 8206BAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-8270-02, Semi-Volatile by Capillary Column GC/MS Mix 2Amber ampule: 1 mL1/28/2013
AccuStandard, IncM-8270-04-ASL, Method 8270B—Base/Neutrals MixAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-8270-23-R1, Method 8270 Semi-Volatile AdditionsAmber ampule: 1 mL1/28/2013
AccuStandard, IncM-E-1179-M, Chloral hydrateAmber ampule: 1 mL1/28/2013
Agilent TechnologiesVeterinary Drugs Checkout MixAmber ampule: 1 mL8/3/2012
Agilent TechnologiesVeterinary Drugs Comprehensive Mix—Submix 6Amber ampule: 1 mL8/3/2012
Agilent TechnologiesForensic Toxicology Comprehensive Mix—Submix 3Amber ampule: 1 mL8/3/2012
Agilent TechnologiesForensic Toxicology Comprehensive Mix—Submix 5Amber ampule: 1 mL8/3/2012
Agilent TechnologiesForensic Toxicology Comprehensive Mix—Submix 2Amber ampule: 1 mL8/3/2012
Agilent TechnologiesForensic Toxicology Checkout MixAmber ampule: 1 mL8/3/2012
Agilent TechnologiesForensic Toxicology Comprehensive Mix—Submix 1Amber ampule: 1 mL12/6/2012
Alltech Associates, Inc2C-T-2 Quik Check, 1.0 mg/mLGlass ampule: 1 mL9/26/2012
Alltech Associates, Inc5-MeO-DMT Quick Check, 1.0 mg/mLGlass ampule: 1 mL9/26/2012
Alltech Associates, IncCarisoprodol Quik Check, 1.0 mg/mLGlass ampule: 1 mL9/26/2012
American Proficiency InstituteAmerican Proficiency Institute SHBG/TestosteroneAmber bottle: 7 mL12/5/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Oral Fluid, OF23Glass vials: 1 ml-200 mL8/14/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, SD17Glass vials: 1 ml-200 mL8/14/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC176Glass vials: 1 ml-200 mL9/27/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC179Glass vials: 1 ml-200 mL10/23/2012
Biochemical Diagnostics, IncSalivabuse Custom Liquid Control Oral Fluid, OF25Glass vials: 1 ml-200 mL10/23/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC177Glass vials: 1 ml-200 mL11/5/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC178Glass vials: 1 ml-200 mL1/24/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Oral Fluid, OF24Glass vials: 1 ml-200 mL1/24/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC181Glass vials: 1 ml-200 mL1/29/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC183Glass vials: 1 ml-200 mL3/12/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC184Glass vials: 1 ml-200 mL3/12/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC180Glass vials: 1 ml-200 mL3/14/2013
Bio-Rad LaboratoriesLiquichek Immunoassay Plus Control Trilevel MiniPakBox: 3 vials, 2.5 mL each11/14/2012
Bio-Rad LaboratoriesLiquichek Immunoassay Plus Control Level 1,2 and 3, TrilevelBox: 12 vials, 5 mL each11/21/2012
Bio-Rad LaboratoriesLiquid Assayed Multiqual Premium, Levels 1-3Box: 6 vials, 5 mL each11/21/2012
Bio-Rad LaboratoriesLiquid Assayed Multiqual Premium, Trilevel MinipakBox: 3 vials, 5 mL each11/21/2012
Bio-Rad LaboratoriesLyphocheck Urine Toxicology Control MiniPak, Cat. No. 470XGlass vial: 25 mL1/11/2013
Bio-Rad LaboratoriesLiquichek Immunoassay Plus Control Level 1Glass vial: 2.5 mL, Box 12 vials2/20/2013
Bio-Rad LaboratoriesLiquichek Immunoassay Plus Control Level 2Glass vial: 2.5 mL, Box 12 vials2/20/2013
Bio-Rad LaboratoriesLiquichek Immunoassay Plus Control Level 3Glass vial: 2.5 mL, Box 12 vials2/20/2013
Cerilliant CorporationBenzodiazepine Mix (1 mg/mL)Glass Ampule: 1 mL7/2/2012
Cerilliant CorporationClass C Mix Urinalysis Internal Standard Fortified MorphineGlass Ampule: 1 mL7/9/2012
Cerilliant CorporationSpice Cannabinoid Mix 2 (0.1 mg/mL)Amber ampule: 1 mL9/26/2012
Cerilliant CorporationSpice Cannabinoid Mix 3 (0.1 mg/mL)Amber ampule: 1 mL9/26/2012
Cerilliant CorporationRetigabine (1 mg/mL)Glass Ampule: 1 mL11/7/2012
Cerilliant Corporation±-Norpseudoephedrine-D3 HCl (0.1 mg/mL)Glass Ampule: 1 mL1/7/2013
Cerilliant CorporationAmobarbital-D5 (0.1 mg/mL)Glass Ampule: 1 mL1/7/2013
Cerilliant Corporation2,5-Dimethoxy-4-(n)-propylthiophenethylamine HCl (2C-T-7 HCl) (1 mg/mL)Glass Ampule: 1 mL1/7/2013
Cerilliant CorporationClass B Mix Urinalysis Internal Standard-8 (0.002-0.2 mg/mL), Pregabalin-D6 (1.0 mg/mL), Codeine-6-beta-glucoronide (1.0 mg/mL), Desomorphine (1.0 mg/mL), Levorphanol-D3 (0.1 mg/mL)Glass ampule: 1 ml1/22/2013
Cerilliant CorporationZaleplon-D4 (0.1 mg/mL)Glass Ampule: 1 mL1/31/2013
Cerilliant CorporationRetigabine-D4 (0.1 mg/mL)Glass ampule: 1ml3/22/2013
Cerilliant CorporationTilidine-D6 HCl (0.1 mg/mL)Glass ampule: 1ml3/22/2013
Cliniqa CorporationTDM Control, Levels 1-3Dropper bottle: 5 mL12/4/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, THC (0.5-50 ng/mL)Glass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Methamphetamine (2-200 ng/mL)Glass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)Glass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Multidrug (THC, Benzoylecgonine, Amphetamine, Methamphetamine, Morphine, Codeine, 6-Acetylmorphine, & PCP) at 0.5-50 ng/mLGlass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, THC (0.5-50 ng/mL)Glass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Methamphetamine (2-200 ng/mL)Glass vial: 5 ml-4 L10/22/2012
Start Printed Page 40178
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)Glass vial: 5 ml-4 L10/22/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Multidrug (THC, Benzoylecgonine, Amphetamine, Methamphetamine, Morphine, Codeine, 6-Acetylmorphine, & PCP) at 0.5-200 ng/mLGlass vial: 5 ml-4 L10/22/2012
Environmental Resource Associates (ERA)USGS-BQS LS 4434 Mix 1Glass Ampule: 2 mL8/9/2012
Environmental Resource Associates (ERA)USGS-BQS LS 4434 Mix 2Glass Ampule: 2 mL8/9/2012
Immunalysis CorporationTapentadol Calibrator Level 1 (100 ng/mL)Glass vial: 10 mL12/11/2012
Immunalysis CorporationTapentadol Calibrator Level 2 (200 ng/mL)Glass vial: 10 mL12/11/2012
Immunalysis CorporationTapentadol Calibrator Level 3 (500 ng/mL)Glass vial: 10 mL12/11/2012
Immunalysis CorporationTapentadol Calibrator Level 4 (1,000 ng/mL)Glass vial: 10 mL12/11/2012
Immunalysis CorporationTapentadol Low Control (150 ng/mL)Glass vial: 10 mL12/11/2012
Immunalysis CorporationTapentadol High Control (250 ng/mL)Glass vial: 10 mL12/11/2012
LGC Limited(S)-(+)-Amphetamine (Dextroamphetamine) 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine-D11 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine-D11 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMethamphetamine ((S)-(+)-Methamphetamine) 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Methamphetamine 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Methamphetamine 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Methamphetamine-D5 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Methamphetamine-D5 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMethcathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL9/24/2012
LGC LimitedMethylphenidate Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL9/24/2012
LGC LimitedAmobarbital 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPentobarbital 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPentobarbital-D5 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPentobarbital-D5 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedSecobarbital 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDA-D5 (rac-3,4-Methylenedioxyamphetamine-D5) 0.1 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDA-D5 (rac-3,4-Methylenedioxyamphetamine-D5) 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MBDB HCl (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-butanamine Hydrochloride) 1.0 mg/mL Methanol (as free base)Glass vial: 1 mL9/24/2012
LGC Limitedrac-MBDB-D5 (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-butanamine-D5) 0.1 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDEA-D5 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D5) 0.1 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDEA-D5 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D5) 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDEA-D6 (rac-3,4-Methylenedioxy-N-ethylamphetamine-D6) 0.1 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDMA-D5 (rac-3,4-Methylenedioxymethamphetamine-D5) 0.1 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-MDMA-D5 (rac-3,4-Methylenedioxymethamphetamine-D5) 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPhencyclidine (PCP) 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPhencyclidine-D5 (PCP-D5) 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPhencyclidine-D5 (PCP-D5) 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine-D3 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine-D3 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine-D6 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine-D6 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedIsocodeine 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedNorcodeine 0.01 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedNorcodeine 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedCodeine N-Oxide 0.01 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedOxycodone-D3 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
Start Printed Page 40179
LGC LimitedOxycodone-D6 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedOxycodone-D6 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedHydromorphone 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedNorhydromorphone Hydrochloride 1.0 mg/mL Methanol (as free base)Glass vial: 1 mL9/24/2012
LGC LimitedPethidine (Meperidine) 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPethidine-D4 (Meperidine-D4) 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedPethidine-D4 (Meperidine-D4) 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMorphine 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMorphine 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMorphine 3-beta-D-Glucuronide 0.1 mg/mL in Methanol/Water (1/1)Glass vial: 1 mL9/24/2012
LGC LimitedMorphine 3-beta-D-Glucuronide 1.0 mg/mL in Methanol with 0.05 percent Sodium Hydroxide (w/v)Glass vial: 1 mL9/24/2012
LGC LimitedMorphine 6-beta-D-Glucuronide 0.1 mg/mL in Methanol/Water (1/1)Glass vial: 1 mL9/24/2012
LGC LimitedMorphine 6-beta-D-Glucuronide 1.0 mg/mL Water/Methanol (80/20)Glass vial: 1 mL9/24/2012
LGC LimitedMorphine-D3 0.1 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMorphine-D3 1.0 mg/mL in MethanolGlass vial: 1 mL9/24/2012
LGC LimitedMorphine N-Oxide 0.01 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC LimitedNormorphine 1.0 mg/mL MethanolGlass vial: 1 mL9/24/2012
LGC Limitedrac-Amphetamine-D10 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D5 (D-label on side chain) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D5 (D-label on side chain) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D6 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D6 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D8 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Amphetamine-D8 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D11 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D11 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D14 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D14 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D8 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D8 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D9 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methamphetamine-D9 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limited(+)-Norpseudoephedrine Hydrochloride (Cathine Hydrochloride) 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limited(R)-(+)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limited(S)-(-)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limited(S)-(-)-Methcathinone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedPhentermine 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFenfluramine Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedMethylphenidate-D9 Hydrochloride 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPipradrol Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedPipradrol Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedGHB Sodium Salt (Sodium Gammahydroxybutyrate) 1.0 mg/mL in Methanol (as free acid)Glass vial: 1 mL11/30/2012
LGC LimitedGHB-D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6) 0.1 mg/mL in Methanol (as free acid)Glass vial: 1 mL11/30/2012
LGC LimitedGHB-D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6) 1.0 mg/mL in Methanol (as free acid)Glass vial: 1 mL11/30/2012
LGC LimitedHexobarbital 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMethohexital 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMethohexital-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPhenobarbital 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPhenobarbital-D5 (D-label on ring) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPhenobarbital-D5 (D-label on ring) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPhenobarbital-D5 (D-label on side chain) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
Start Printed Page 40180
LGC LimitedPhenobarbital-D5 (D-label on side chain) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMethaqualone 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMethaqualone-D7 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedClonazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedClonazepam-D4 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedChlordiazepoxide 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedChlordiazepoxide-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBromazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBromazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedClobazam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDelorazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedEstazolam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedEstazolam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFlunitrazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFlunitrazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFlunitrazepam-D7 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPrazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPrazepam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDiazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDiazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDiazepam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDiazepam-D5 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFlurazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFlurazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedLormetazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedZaleplon 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPregabalin 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedPregabalin-D6 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedZolpidem Tartrate 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedZolpidem-D6 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedZopiclone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedZopiclone Oxide 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedZopiclone-D4 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedMeprobamate 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNitrazepam 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNitrazepam 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNitrazepam-D5 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedOxazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedOxazepam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedOxazepam-D5 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNordazepam (Nordiazepam) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNordazepam (Nordiazepam) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNordazepam-D5 (Nordiazepam-D5) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNordazepam-D5 (Nordiazepam-D5) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedAlprazolam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedAlprazolam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedAlprazolam-D5 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMethyltestosterone (17alpha-Methyltestosterone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedMidazolam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedMidazolam-D4 Maleate 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedLorazepam 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLorazepam 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLorazepam Acetate ((3RS)-7-Chloro-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl Acetate) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLorazepam-D4 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLorazepam-D4 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTetrazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTriazolam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTriazolam-D4 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTemazepam 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTemazepam 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTemazepam-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedTemazepam-D5 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedAndrostanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedAndrostenedione (Androst-4-ene-3, 17-dione) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
Start Printed Page 40181
LGC LimitedBoldenone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedFluoxymesterone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedMesterolone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedMethandienone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNandrolone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNorandrostenedione (19-Norandrost-4-ene-3,17-dione) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNorethandrolone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedStanozolol 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedStanozolol-D3 0.1 mg/mL in 1,2-DimethoxyethaneGlass vial: 1 mL11/30/2012
LGC LimitedTestosterone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTestosterone Benzoate 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTestosterone Isocaproate 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTestosterone Propionate 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTrenbolone 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedRCS-4 (DD-001, (4-Methoxyphenyl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedJWH-081 ((4-Methoxynaphthalen-1-yl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedJWH-122 ((4-Methylnaphthalen-1-yl)(1-pentylindol-3-yl)methanone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedJWH-203 (2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)ethanone) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedKetamine Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedKetamine-D4 Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedIso-LSD (Lysergic Acid Diethylamide) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLAMPA (Lysergic Acid N-Methyl-N-propylamide) 0.025 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLSD (Lysergic Acid Diethylamide) 0.025 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLSD-D3 (Lysergic Acid Diethylamide-D3) 0.025 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedPMA HCl (p-Methoxyamphetamine) 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limitedrac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-MDEA (rac-3,4-Methylenedioxy-N-ethylamphetamine) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limited1-Methylamino-1-(3,4-methylenedioxyphenyl)propane Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limitedrac-BDB HCl (rac-3,4-Methylenedioxyphenyl-2-butanamine Hydrochloride) 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC Limitedrac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBufotenine 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedMethylone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedMethylone-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedCocaine 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedCocaine-D3 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedCocaine-D3 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNorcocaine Hydrochloride 1.0 mg/mL in Acetonitrile (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedNorcocaine-D3 Hydrochloride 0.1 mg/mL in Acetonitrile (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedO-Methylcodeine 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedBuprenorphine 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBuprenorphine 3-beta-D-Glucuronide 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBuprenorphine-D4 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDihydrocodeine Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedDihydrocodeine-D6 Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedNoroxycodone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
Start Printed Page 40182
LGC LimitedNoroxycodone-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedOxycodone 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedOxycodone-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDihydromorphine 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedHydromorphone-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedAnhydroecgonine Hydrochloride 1.0 mg/mL in Acetonitrile (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedAnhydroecgonine Methyl Ester 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedBenzoylecgonine 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBenzoylecgonine-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBenzoylecgonine-D3 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBenzoylecgonine-D8 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedBenzoylecgonine-D8 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedCocaethylene (Benzoylethylecgonine) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedCocaethylene-D3 (Benzoylethylecgonine-D3) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedCocaethylene-D8 (Benzoylethylecgonine-D8) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedEcgonine 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedEcgonine Ethyl Ester 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedEcgonine Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedEcgonine Methyl Ester 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedEcgonine Methyl Ester 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedEcgonine-D3 Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedEcgonine-D3 Methyl Ester 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedEthylmorphine 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedHydrocodone 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedHydrocodone-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedHydrocodone-D6 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNorhydrocodone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedHeroin (Diacetylmorphine) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedHeroin-D9 (Diacetylmorphine-D9) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedHeroin-D9 (Diacetylmorphine-D9) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone-D3 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone-D9 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedrac-Methadone-D9 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedDextropropoxyphene 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedDextropropoxyphene 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limitedrac-Propoxyphene-D11 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limitedrac-Propoxyphene-D11 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limitedrac-Propoxyphene-D5 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limitedrac-Propoxyphene-D5 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine-D3 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine-D3 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine-D6 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited6-Acetylmorphine-D6 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedAcetylcodeine 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedAcetylcodeine 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedNordihydromorphine Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedOxymorphone 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedOxymorphone-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedOxymorphone-D3 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedNoroxymorphone Hydrochloride 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedNoroxymorphone Hydrochloride 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedButorphanol Tartrate 1.0 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
LGC LimitedSufentanil Citrate 0.1 mg/mL in Methanol (as free base)Glass vial: 1 mL11/30/2012
Start Printed Page 40183
LGC Limitedcis-Tilidine (Ethyl (1R,2RS)-2-(Dimethylamino)-1-phenylcyclohex-3-enecarboxylate) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedTilidine 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
Microgenics CorporationAbbott TDM Multiconstituent Calibrator (CAL 1-6) Catalog Number: 5P04-01Box: 7 vials; 5 mL each7/2/2012
Microgenics CorporationThermo Scientific DRI Opiate Assay Catalog Number: 100014602Vial: 18 mL, Box: 3 vials1/30/2013
Microgenics CorporationThermo Scientific DRI Cannabinoid Assay Catalog Number: 10014665Vial: 18 mL, Box: 3 vials1/30/2013
Microgenics CorporationThermo Scientific Phencyclidine Assay Catalog Number: 10014673Vial: 18 mL, Box: 3 vials1/30/2013
Microgenics CorporationThermo Scientific Ecstacy Assay Catalog Number: 10014681Vial: 18 mL, Box: 3 vials1/30/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Calibrator 1: Catalog Number 10016362Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Calibrator 2: Catalog Number 10063Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Calibrator 3: Catalog Number 10016364Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Control 1: Catalog Number 10017686Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Control 2: Catalog Number 10017687Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Methamphetamine OFT Control 3: Catalog Number 1007688Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Calibrator 1: Catalog Number 10016882Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Calibrator 2: Catalog Number 10016883Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Calibrator 3: Catalog Number 10016884Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Control 1: Catalog Number 10017711Vial: 15 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Control 2: Catalog Number 10017712Vial: 15 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA Multi-Drug OFT Control 3: Catalog Number 10017713Vial: 15 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Calibrator 1: Catalog Number 10016700Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Calibrator 2: Catalog Number 10016701Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Calibrator 3: Catalog Number 10016702Vial: 5 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Control 1: Catalog Number 10017702Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Control 2: Catalog Number 10017703Vial: 10 mL; Box: 1 vial2/11/2013
Microgenics CorporationThermo Scientific CEDIA THC OFT Control 3: Catalog Number 10017704Vial: 10 mL; Box: 1 vial2/11/2013
Ortho Clinical Diagnostics, IncVITROS Immunodiagnostics Products Testosterone Reagent PackPlastic chamber: 8.4 mL9/28/2012
Ortho Clinical Diagnostics, IncVITROS Immunodiagnostics Products Estradiol Reagent PackPlastic chamber: 13.3 mL9/28/2012
Ortho Clinical Diagnostics, IncVITROS Immunodiagnostics Products Testosterone Calibrators (1-3)Box: 3 vials; 2 mL each10/19/2012
Ortho Clinical Diagnostics, IncVITROS Immunodiagnostics Products Testosterone Controls (1-3)Box: 9 vials; 1 mL each10/19/2012
Ortho Clinical Diagnostics, IncVITROS Immunodiagnostics Products Testosterone Range Verifiers (Low and High)Box: 4 vials; 1-1.5 mL each10/19/2012
RestekCustom Revised Appendix IX Mix #1Glass vial: 1.3 mL2/14/2013
Restek CorporationProduct and Reactor Samples StandardAmpule: 2 mL10/12/2012
Restek Corporation8270 Supplemental Standard #1Ampule: 2 mL12/13/2012
Siemens Healthcare Diagnostics IncTTST Stock X (Bulk)Stock container: 50 mL-1 L7/26/2012
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 1Bulk container: 4 mL-100 L7/26/2012
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 2Bulk container: 4 mL-100 L7/26/2012
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 3Bulk container: 4 mL-100 L7/26/2012
Start Printed Page 40184
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 4Bulk container: 4 mL-100 L7/26/2012
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 5Bulk container: 4 mL-100 L7/26/2012
Siemens Healthcare Diagnostics IncVS TTST Cal Bulk Soln Level 6Bulk container: 4 mL-100 L7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL AVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL BVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL CVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL DVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL EVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista TTST CAL FVial: 1 mL7/26/2012
Siemens Healthcare Diagnostics IncDimension Vista System TTST CALBox: 12 vials; 1 ml each7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 1 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 2 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 3 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 4 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 5 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST Lvl 6 BulkBulk container: 4 mL-20 L7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 1 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 2 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 3 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 4 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 5 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncMP TTST CAL Lvl 6 FCVial: 1-5 mL7/26/2012
Siemens Healthcare Diagnostics IncTTST Stock S (Bulk)Stock container: 50 mL-1 L7/26/2012
Siemens Healthcare Diagnostics IncTTST Stock T (Bulk)Stock container: 50 mL-1 L7/26/2012
Siemens Healthcare Diagnostics IncEstradiol DiluentPlastic container: 0.5L-1.0L11/14/2012
Siemens Healthcare Diagnostics IncDimension Vista Drug 1 CAL Pilot, Level BPlastic test tube: 15 mL12/3/2012
Supelco, IncTitan C18 Batch Test 1 MixGlass ampule: 1 mL2/28/2013

The Deputy Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II below is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II below and specifically described in the application materials received by DEA, are not exempt from application of any part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date listed below that was provided in the determination letters to the individual requesters.

Chart II

SupplierProduct nameFormApplication date
Agilent TechnologiesForensic Toxicology Comprehensive Mix-Submix 9AAmpule: 1 mL12/6/2012
Start Printed Page 40185
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC177Glass vials: 1 ml-200 mL10/11/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC178Glass vials: 1 ml-200 mL10/23/2012
Biochemical Diagnostics, IncSalivabuse Custom Liquid Control Oral Fluid, OF24Glass vials: 1 ml-200 mL10/23/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC180Glass vials: 1 ml-200 mL12/14/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC181Glass vials: 1 ml-200 mL12/14/2012
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC182Glass vials: 1 ml-2 L1/22/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC180Glass vials: 1 ml-200 mL1/29/2013
Biochemical Diagnostics, IncDetectabuse Custom Liquid Control Urine, MC182Glass vials: 1 ml-2 L2/14/2013
Cerilliant Corporation(-)-11-nor-9-Carboxy-delta9-THC (1 mg/mL)Glass ampule: 5 mL7/6/2012
Cerilliant CorporationCocaine HCl (10 mg/mL)Glass Ampule: 1 mL7/6/2012
Cerilliant CorporationLacosamide (10 mg/mL)Glass Ampule: 1 mL9/12/2012
Cliniqa CorporationTDM Control, Levels 1-3 BulkPlastic Container: 500 L12/4/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, THC (0.5-50 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Methamphetamine (2-200 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Controls, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at 0.5-50 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, THC (0.5-50 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Methamphetamine (2-200 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine, Morphine, Phencyclidine (2-200 ng/mL)Glass vial: 5 ml-4 L8/9/2012
ElSohly Laboratories, IncELI Oral Fluid Calibrators, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at 0.5-200 ng/mL)Glass vial: 5 ml-4 L8/9/2012
LGC LimitedLAMPA (Lysergic Acid N-Methyl-N-propylamide) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLSD (Lysergic Acid Diethylamide) 1.0 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC LimitedLSD-D3 (Lysergic Acid Diethylamide-D3) 0.1 mg/mL in AcetonitrileGlass vial: 1 mL11/30/2012
LGC Limited(-)-Cannabidiol 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedCannabinol 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limited(-)-delta9-THC (Dronabinol) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limited(-)-delta9-THC-D3 (Dronabinol-D3) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Hydroxy-delta9-THC ((6aRS,10aRS)-11-Hydroxy-delta9-tetrahydrocannabinol) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Hydroxy-delta9-THC ((6aRS,10aRS)-11-Hydroxy-delta9-tetrahydrocannabinol) 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Hydroxy-delta9-THC-D3 (trans-11-Hydroxy-delta9-tetrahydrocannabinol-D3) 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Nor-9-carboxy-delta9-THC 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Nor-9-carboxy-delta9-THC-D3 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC Limitedtrans-11-Nor-9-carboxy-delta9-THC-D3 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFentanyl 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFentanyl 1.0 mg/mL in MethanolGlass vial: 1 mL11/30/2012
LGC LimitedFentanyl-D5 0.1 mg/mL in MethanolGlass vial: 1 mL11/30/2012
Siemens Healthcare Diagnostics IncDimension Vista Drug 1 CAL Bulk, Level BPlastic container: 4-100 L12/3/2012

Scope of Approval

The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those sections of the CSA and the CFR that are specifically identified. Pursuant to 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. Pursuant to 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used by the manufacturer and may not be distributed by the manufacturer for any purpose or transported to other facilities.

Additional exempt chemical preparation requests received between July 1, 2012, and March 31, 2013, and not otherwise referenced in this order may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future Federal Register publication.

DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR Start Printed Page 401861308.24(a). All other requirements of the CSA and the CFR apply, including, but not limited to, registration as an importer as required by 21 U.S.C. 957.

Chemical Preparations Containing Newly Controlled Substances

The statutory authority for exempt chemical preparations is based on the control status of substances contained within a preparation, the intended administration of a preparation, and the packaged form of a preparation. DEA conducts a case-by-case analysis of each application for exemption to determine whether exemption of a preparation from certain provisions of the CSA is appropriate pursuant to the specified statutory and regulatory requirements.

Most exempt chemical preparations have remained effective until the holder of a specific exempt chemical preparation specifically requested that the exemption be terminated. The CSA allows for modifications to the controlled substances schedules to add, remove, or change the schedule of substances thus resulting in periodic modifications to the control status of various substances. 21 U.S.C. 811(a). Since the CSA was enacted in 1970, DEA has on several occasions added to, removed from, or modified the schedules of controlled substances in accordance with the CSA. Such changes may result in the non-compliance of exempt chemical preparations with current statutes or regulations if chemical preparations that have already obtained exempt status contain newly controlled substances. For example, although an exempt chemical preparation may continue to be packaged in the same manner as when it was approved, non-controlled substances in the preparation may become controlled, thus prompting the need for a new application for exemption of the chemical preparation to ensure continued compliance. Other preparations that previously contained no controlled substances may contain newly controlled substances and thus would require an application for exemption.

DEA reviews applications for chemical preparation exemptions based on the statutes and regulations that are in place at the time of the application, including the control status of substances included in the preparation. DEA must remain vigilant to ensure that exempt chemical preparations remain consistent with the standards set forth in the CSA and its implementing regulations. As such, DEA reminds the public that any chemical preparation, regardless of whether it was previously exempt, that contains a newly controlled substance will require a new application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR 1308.23-1308.24.

Review of Exemptions Pursuant to 21 U.S.C. 811(g)(3)

Based on inquiries received from industry, DEA is conducting a comprehensive review of the exempt chemical preparation regulations. DEA's regulations at 21 CFR 1308.24(a) state that approved chemical preparations are exempt from certain provisions of both Subchapter I and Subchapter II of the CSA: “The chemical preparations and mixtures approved pursuant to 1308.23 are exempt from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21 U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the extent described in paragraphs (b) to (h) of this section.” Pursuant to its regulations, DEA has provided exemptions from the application of section 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the Act (21 U.S.C. 822-823, 825-829, 952-954) and 21 CFR 1301.74 since the implementation of the regulations in the early 1970s. Until DEA's analysis of the exemption regulations is complete, DEA will continue to review and provide exemptions to chemical preparations consistent with the implementing regulations, when warranted. DEA will publish a future notice regarding the outcome of DEA's review of its regulations with respect to the exemption of chemical preparations.

Opportunity for Comment

Pursuant to 21 CFR 1308.23, any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Deputy Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed.

Approved Exempt Chemical Preparations Are Posted on DEA's Web Site

A list of all current exemptions, including those listed in this order, is available on DEA's Web site at http://www.DEAdiversion.usdoj.gov/​schedules/​exempt/​exempt_​chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference.

Start Signature

Dated: June 17, 2013.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

Footnotes

1.  This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100 and subsequently redelegated to the Deputy Assistant Administrator pursuant to the Appendix to Subpart R of 28 CFR 0.104.

Back to Citation

[FR Doc. 2013-16010 Filed 7-2-13; 8:45 am]

BILLING CODE 4410-09-P